Winan van Houdt: ESMO24 Barcelona is almost over
Winan van Houdt posted on LinkedIn:
“ESMO24 Barcelona is almost over – was nice to see the ideas and plans of our scientific sarcoma track subcommittee come to fruition. It was a good collaboration as always, led by track chair Bernd Kasper
Also happy to give a lecture in the multidisciplinary session discussing response after neo-adjuvant treatment of soft tissue sarcoma and the impact on surgery.
Together, we, as the international sarcoma community, try to constantly improve our multidisciplinary treatment strategies since we want to do better for our patients and give them a better chance and more hope.”
Source: Winan van Houdt/LinkedIn
Winan van Houdt is a surgical oncologist at Antoni van Leeuwenhoek, specializing in rare cancers such as GIST, soft tissue sarcomas (retroperitoneal, intra-abdominal, and extremity), melanoma, desmoid tumors, and non-melanoma skin cancers.
He serves as the Program Coordinator for Rare Cancers at the Netherlands Cancer Institute and chairs the Soft Tissue and Bone Sarcoma Group (STBSG) at the EORTC. Van Houdt is also a member of the Scientific Steering Committee for the Sarcoma Track at ESMO 2024.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023